Marianna Foldvari

Summary

Affiliation: University of Waterloo
Country: Canada

Publications

  1. ncbi request reprint Recent progress in the application of nanotechnology for prevention and treatment of human papillomavirus infection
    Marianna Foldvari
    School of Pharmacy and Institute of Nanotechnology, University of Waterloo, Waterloo, ON, Canada
    Ther Deliv 3:1005-17. 2012
  2. doi request reprint HPV infections: can they be eradicated using nanotechnology?
    Marianna Foldvari
    School of Pharmacy, Waterloo Institute of Nanotechnology, University of Waterloo, Waterloo, Ontario, Canada
    Nanomedicine 8:131-5. 2012
  3. doi request reprint Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues
    Marianna Foldvari
    Faculty of Science, School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada
    Nanomedicine 4:183-200. 2008
  4. doi request reprint Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties
    Marianna Foldvari
    School of Pharmacy, Faculty of Science, University of Waterloo, Waterloo, Ontario, Canada
    Nanomedicine 4:173-82. 2008
  5. doi request reprint Topical delivery of interferon alpha by biphasic vesicles: evidence for a novel nanopathway across the stratum corneum
    Marianna Foldvari
    School of Pharmacy, University of Waterloo, 200 University Avenue West, Waterloo, ON N2L 3G1, Canada
    Mol Pharm 7:751-62. 2010
  6. ncbi request reprint Biphasic vesicles for topical delivery of interferon alpha in human volunteers and treatment of patients with human papillomavirus infections
    Marianna Foldvari
    School of Pharmacy, University of Waterloo, Waterloo, ON, Canada
    Curr Drug Deliv 8:307-19. 2011
  7. ncbi request reprint Gemini surfactants: a new family of building blocks for non-viral gene delivery systems
    Shawn D Wettig
    School of Pharmacy, University of Waterloo, 200 University Avenue W, Waterloo, ON N2L 3G1, Canada
    Curr Gene Ther 8:9-23. 2008
  8. doi request reprint Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma
    Samih Alqawlaq
    School of Pharmacy, University of Waterloo, 200 University Avenue West, Waterloo, ON, Canada
    Nanomedicine (Lond) 7:1067-83. 2012
  9. doi request reprint Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability
    Shadi H Moghadam
    School of Pharmacy, University of Waterloo, 200 University Avenue West, Waterloo, ON, Canada, N2L 3G1
    Mol Pharm 10:2248-60. 2013
  10. ncbi request reprint Non-viral nucleic acid delivery: key challenges and future directions
    Mahmoud Elsabahy
    School of Pharmacy, University of Waterloo, 10 Victoria St S, Kitchener ON N2G 1C5, Canada
    Curr Drug Deliv 8:235-44. 2011

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Recent progress in the application of nanotechnology for prevention and treatment of human papillomavirus infection
    Marianna Foldvari
    School of Pharmacy and Institute of Nanotechnology, University of Waterloo, Waterloo, ON, Canada
    Ther Deliv 3:1005-17. 2012
    ....
  2. doi request reprint HPV infections: can they be eradicated using nanotechnology?
    Marianna Foldvari
    School of Pharmacy, Waterloo Institute of Nanotechnology, University of Waterloo, Waterloo, Ontario, Canada
    Nanomedicine 8:131-5. 2012
    ..Nanotechnology tools employed in the development of vaccines and a noninvasive treatment may provide a significant advancement in the global combat against this disease...
  3. doi request reprint Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues
    Marianna Foldvari
    Faculty of Science, School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada
    Nanomedicine 4:183-200. 2008
    ..multi-walled CNTs), length and aspect ratio, surface area, degree of aggregation, extent of oxidation, surface topology, bound functional group(s), and method of manufacturing...
  4. doi request reprint Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties
    Marianna Foldvari
    School of Pharmacy, Faculty of Science, University of Waterloo, Waterloo, Ontario, Canada
    Nanomedicine 4:173-82. 2008
    ....
  5. doi request reprint Topical delivery of interferon alpha by biphasic vesicles: evidence for a novel nanopathway across the stratum corneum
    Marianna Foldvari
    School of Pharmacy, University of Waterloo, 200 University Avenue West, Waterloo, ON N2L 3G1, Canada
    Mol Pharm 7:751-62. 2010
    ..It is hypothesized that induction of a Pn3m cubic phase in stratum corneum lipids could make dermal and transdermal delivery of other macromolecules also possible...
  6. ncbi request reprint Biphasic vesicles for topical delivery of interferon alpha in human volunteers and treatment of patients with human papillomavirus infections
    Marianna Foldvari
    School of Pharmacy, University of Waterloo, Waterloo, ON, Canada
    Curr Drug Deliv 8:307-19. 2011
    ..CONCLUSIONS. Biphasic vesicles delivered clinically significant levels of IFN α across intact human skin and elicited marked therapeutic effect in patients...
  7. ncbi request reprint Gemini surfactants: a new family of building blocks for non-viral gene delivery systems
    Shawn D Wettig
    School of Pharmacy, University of Waterloo, 200 University Avenue W, Waterloo, ON N2L 3G1, Canada
    Curr Gene Ther 8:9-23. 2008
    ..In vivo transfection using gemini surfactants has been demonstrated in only three cases, and in a recent study the transfection was linked to a specific therapeutic response...
  8. doi request reprint Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma
    Samih Alqawlaq
    School of Pharmacy, University of Waterloo, 200 University Avenue West, Waterloo, ON, Canada
    Nanomedicine (Lond) 7:1067-83. 2012
    ....
  9. doi request reprint Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability
    Shadi H Moghadam
    School of Pharmacy, University of Waterloo, 200 University Avenue West, Waterloo, ON, Canada, N2L 3G1
    Mol Pharm 10:2248-60. 2013
    ..Interestingly, in vitro skin permeation studies indicated that, in most cases, absorption of IFNα was low and that an increase in SC lipid disorder does not correspond to an increase in IFNα absorption...
  10. ncbi request reprint Non-viral nucleic acid delivery: key challenges and future directions
    Mahmoud Elsabahy
    School of Pharmacy, University of Waterloo, 10 Victoria St S, Kitchener ON N2G 1C5, Canada
    Curr Drug Deliv 8:235-44. 2011
    ..This review discusses some of the strategies that have been employed to overcome the barriers towards successful gene delivery...
  11. pmc Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients
    Marina V Ivanova
    School of Pharmacy, University of Waterloo, Waterloo, ON, Canada
    Int J Nanomedicine 7:403-15. 2012
    ..In this work, we describe the characterization of several commercially available and two in-house-produced CNT samples and discuss the physicochemical profiles that will support their use in nanomedicine...
  12. ncbi request reprint Biphasic vesicles: a novel topical drug delivery system
    Marianna Foldvari
    School of Pharmacy, University of Waterloo, Waterloo, ON N2L 361, Canada
    J Biomed Nanotechnol 6:543-57. 2010
    ..This paper reviews the application of a novel topical delivery system, biphasic vesicles built from nanoscale components, to the delivery of several therapeutic agents and vaccine antigens and discusses progress toward clinical use...
  13. ncbi request reprint Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles
    Shawn D Wettig
    School of Pharmacy, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, Canada N2L 3G1
    J Gene Med 9:649-58. 2007
    ....